Vascular pathobiology in chronic liver disease and cirrhosis - Current status and future directions

被引:221
|
作者
Iwakiri, Yasuko [1 ]
Shah, Vijay [2 ]
Rockey, Don C. [3 ]
机构
[1] Yale Univ Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[3] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
基金
美国国家卫生研究院;
关键词
Endothelial cell; Pericyte; Sinusoid; Pressure; Resistance; Therapy; NITRIC-OXIDE SYNTHASE; SINUSOIDAL ENDOTHELIAL-CELLS; PORTAL HYPERTENSIVE-RATS; HEPATIC STELLATE CELLS; SCANNING ELECTRON-MICROSCOPE; FIBROBLAST-GROWTH-FACTOR; FARNESOID X RECEPTOR; SMOOTH MUSCLE ACTIN; IN-VIVO; GENE-TRANSFER;
D O I
10.1016/j.jhep.2014.05.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic liver disease is associated with remarkable alterations in the intra- and extrahepatic vasculature. Because of these changes, the fields of liver vasculature and portal hypertension have recently become closely integrated within the broader vascular biology discipline. As developments in vascular biology have evolved, a deeper understanding of vascular processes has led to a better understanding of the mechanisms of the dynamic vascular changes associated with portal hypertension and chronic liver disease. In this context, hepatic vascular cells, such as sinusoidal endothelial cells and pericyte-like hepatic stellate cells, are closely associated with one another, where they have paracrine and autocrine effects on each other and themselves. These cells play important roles in the pathogenesis of liver fibrosis/cirrhosis and portal hypertension. Further, a variety of signaling pathways have recently come to light. These include growth factor pathways involving cytokines such as transforming growth factor beta, platelet derived growth factor, and others as well as a variety of vasoactive peptides and other molecules. An early and consistent feature of liver injury is the development of an increase in intra-hepatic resistance; this is associated with changes in hepatic vascular cells and their signaling pathway that cause portal hypertension. A critical concept is that this process aggregates signals to the extrahepatic circulation, causing derangement in this system's cells and signaling pathways, which ultimately leads to the collateral vessel formation and arterial vasodilation in the splanchnic and systemic circulation, which by virtue of the hydraulic derivation of Ohm's law (pressure = resistance x flow), worsens portal hypertension. This review provides a detailed review of the current status and future direction of the basic biology of portal hypertension with a focus on the physiology, pathophysiology, and signaling of cells within the liver, as well as those in the mesenteric vascular circulation. Translational implications of recent research and the future directions that it points to are also highlighted. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:912 / 924
页数:13
相关论文
共 50 条
  • [21] Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions
    Detjen, Katharina
    Hammerich, Linda
    Oezdirik, Burcin
    Demir, Munevver
    Wiedenmann, Bertram
    Tacke, Frank
    Jann, Henning
    Roderburg, Christoph
    NEUROENDOCRINOLOGY, 2021, 111 (03) : 217 - 236
  • [22] The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives
    Ambrosino, Nicolino
    Paggiaro, Pierluigi
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (01) : 117 - 127
  • [23] Wilson disease: Current status and the future
    Schilsky, Michael L.
    BIOCHIMIE, 2009, 91 (10) : 1278 - 1281
  • [24] Nanotechnology in Retinal Disease: Current Concepts and Future Directions
    Mehta, Nalin J.
    Mehta, Sachin N.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 40 (01) : 3 - 12
  • [25] Pulmonary Bacterial Infection and Liver Cirrhosis: Current Status and Treatment
    Zhao, Yingying
    Yang, Song
    Xing, Huichun
    INFECTIOUS MICROBES & DISEASES, 2024, 6 (01): : 5 - 10
  • [26] Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions
    Liu, Jingfeng
    Yuan, Zhiming
    Wang, Qingwen
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (04) : 692 - 699
  • [27] Attention Bias Modification for Anxiety and Phobias: Current Status and Future Directions
    Kuckertz, Jennie M.
    Amir, Nader
    CURRENT PSYCHIATRY REPORTS, 2015, 17 (02)
  • [28] Current status, pitfalls and future directions in the diagnosis and therapy of lymphatic malformation
    Sun, Ravi W.
    Tuchin, Valery V.
    Zharov, Vladimir P.
    Galanzha, Ekaterina I.
    Richter, Gresham T.
    JOURNAL OF BIOPHOTONICS, 2018, 11 (08)
  • [29] Targeted therapy in acute myeloid leukaemia: current status and future directions
    Stapnes, Camilla
    Gjertsen, Bjorn Tore
    Reikvam, Hakon
    Bruserud, Oystein
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 433 - 455
  • [30] The development and validation of tau PET tracers: current status and future directions
    Okamura, Nobuyuki
    Harada, Ryuichi
    Ishiki, Aiko
    Kikuchi, Akio
    Nakamura, Tadaho
    Kudo, Yukitsuka
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (04) : 305 - 316